Positive airway pressure devices market to reach US $3.5 billion by 2028 – Globaldata

Global market value for positive airway pressure (PAP) devices, currently estimated at US $1.8 billion, is expected to expand to US $ 3.5 billion by 2028, at a compound annual growth rate (CAGR) of 7.7%, according to GlobalData. The company’s report, ‘Positive Airway Pressure Devices – Anesthesia & Respiratory Devices Market Analysis and Forecast Model’, reveals that growth will be driven by the shift in patient care from hospital to home, increasing prevalence of obstructive sleep apnea (OSA) and chronic obstructive pulmonary disease (COPD). PAP devices, most commonly used in hospitals and long-term care facilities, are becoming increasingly popular in home settings. However, they are not designed to be life-support devices and are not intended to replace advanced mechanical ventilators. PAP devices are there to improve nocturnal alveolar hypoventilation for patients with COPD or OSA. Tina Deng, medical devices analyst at GlobalData, comments, “Non-invasive ventilation at home improves the quality and tolerance of the treatment. Additionally, it can reduce healthcare costs associated with the management of patients with severe COPD by greatly increasing the time…

Choose your subscription to read more